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A review of contemporary contraceptives 
and sterilization techniques for feral horses
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Abstract: This commentary provides a brief review of the history of contraceptive 
research eff orts for feral horses (Equus ferus caballus) as well as the contraceptives and 
sterilization techniques currently available for feral horses. Porcine zona pellucida (PZP) 
immunocontraceptives have received the most attention and use over the past 40 years, 
but other treatments such as the GnRH vaccine Gonacon™-Equine are also available. 
Optimization of these treatments as well as the development of other molecular approaches, 
intrauterine devices, and surgical techniques is ongoing. 
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Since the late ₁₉₇₀s, researchers have sought 
a safe and eff ective equine contraceptive to help 
reduce population growth rates of feral horses 
(Equus ferus caballus) and burros (E. asinus). A 
good treatment that is safe, practical, eff ective, 
and long lasting has not yet been developed. 
Even after a treatment is developed that is 
eff ective for individual animals, there remain 
signifi cant hurdles at the population level that 
must be overcome to reduce population growth 
rates (Garrott  2018). 
Early fertility control eff orts focused on both 
male and female contraception. However, 
as early as 1980, scientists with the National 
Research Council (NRC), part of the National 
Academies of Science, recommended that wild 
horse contraceptive eff orts focus on reducing 
fertility in mares (NRC 1982). They recognized 
the polygynandrous nature of feral horses 
where multiple males may breed the same 
or multiple females. While it is true that wild 
horses live in harems that include a dominant 
stallion, much of the breeding may also be 
done by other stallions, and harem structures 
are fl uid over time. It has been demonstrated 
that up to one third of foals may be sired by 
stallions that are not affi  liated with a mare’s 
band (Bowling and Touchberry 1990). 
Steroid hormones to vaccines
Early contraceptive studies in stallions and 
mares used steroid hormones to alter fertility. 
While there was some success in mares, the 
treatments were cumbersome to administer, 
and there were concerns about the potential for 
persistence of the hormones in the food chain 
and the environment. About this same time, 
studies were done with surgical vasectomies 
applied to harem stallions. There was a small 
eff ect noted in 1 of the 2 groups studied, but 
it was short lived. The researchers concluded 
that, while it may be eff ective at the individual 
horse level, the effi  cacy of vasectomizing males 
for population growth suppression over time 
was doubtful. 
As att ention turned away from using steroid 
hormones to alter fertility, porcine zona 
pellucida (PZP) vaccines were developed in 
laboratory rodents and later applied to horses 
(Liu et al. 1989, Kirkpatrick et al. 1992). The 
PZP vaccine contains a glycoprotein antigen 
harvested from pig (Sus scrofa domesticus) 
ovaries. When mixed with a powerful adjuvant 
(in most cases it is emulsifi ed with Freund’s 
adjuvant), it stimulates the mare’s immune 
system to make antibodies to ZP proteins. These 
antibodies block fertilization of the egg and over 
time bind to zona proteins in the ovary causing 
it to shrink and become nonfunctional. The 
most widely used PZP vaccine is Zonastat-H®. 
This liquid immunocontraceptive can be hand 
injected or darted into mares. When a booster 
shot is also administered about 30 days later 
and about 1–2 months prior to the breeding 
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season, it is highly eff ective at preventing 
conception for 1 year, with only about 10–20% 
of treated mares foaling each year. In smaller 
herds where the number of animals is at or 
very close to the desired population numbers, 
or the Appropriate Management Level (AML), 
Zonastat-H can successfully reduce or even 
eliminate the need to gather and remove 
animals over time. 
The Bureau of Land Management (BLM) is 
currently using this approach in several herds 
(BLM 2017). The biggest limitation to this 
treatment is that it must be administered every 
year. Most animals on BLM ranges cannot be 
approached closely enough to allow darting, 
and repeated annual roundups to allow hand 
injecting the treatment get more diffi  cult with 
each repetition, usually becoming impractical 
and ineff ective after 2 or 3 iterations. Another 
limitation of this approach is how long it takes 
to achieve the AML when herds are even 
modestly above the desired numbers. The 
so-called Assateague prescription, where the 
vast majority of mares was darted every year 
(Kirkpatrick and Turner 2008), was eventually 
eff ective at achieving population targets on a 
small barrier island, but it took 13 years before 
a decline in numbers was achieved and several 
additional years before AML was achieved. 
That population of 156 horses started in 1993 
only 30% over the desired AML of 120 horses, 
had 143 horses after 13 years, and today has 
about 90 horses. For comparison, many wild 
horse herds managed by the BLM in the west 
are currently at levels >100% greater than AML.
The quest for a longer-lasting PZP treatment 
began about the same time that Zonastat-H was 
being developed. An early study of the pelleted 
“PZP-22” treatment was most promising with 
only 6–18% of mares reported foaling in the 
fi rst 2 years of the Clan Alpine study (Turner 
et al. 2007) and 30–40% foaling in years 3 and 
4. Unfortunately, this level of success has never 
been repeated, with several captive and free-
ranging trials reporting 25, 30, or even 70% 
foaling in the fi rst 2 years following treatment. 
The reasons for this poor performance mostly 
remain a mystery. Recently, success of 15–40% 
foaling over a 3-year period was reported 
with reformulated PZP-22 after additional 
booster treatments (Rutberg et al. 2017), but 
whether or not this can be repeated remains 
to be seen. Currently, PZP-22 is the treatment 
used most frequently by the BLM; at the very 
least, it usually provides 1 year of good effi  cacy 
without requiring a 30-day booster shot, and 
when boostered 1–2 years later, effi  cacy should 
improve.
Spay Vac®, another formulation of PZP developed 
to off er longer-lasting effi  cacy, uses similar PZP 
antigens with a unique liposome technology 
expected to provide several years of effi  cacy. As 
with PZP-22, an initial study of the treatment 
was promising (Killian et al. 2008). However, 
subsequent trials aimed at demonstrating long-
term effi  cacy in a captive pasture breeding 
sett ing could not duplicate the same results 
and in fact showed reasonable effi  cacy in 1 year 
(15% foaling) but poor effi  cacy over time with 
up to 70% of treated mares foaling (Roelle et al. 
2017). Although this vaccine is not commercially 
available at this time, the proponents of the 
product have regrouped and hope to conduct 
testing of a new formulation of Spay Vac in the 
future (Bechert and Fraker 2018). Although this 
product shares the same limitations inherent 
to the PZP antigen as Zonastat-H and PZP-
22, in some species including occasionally 
horses, it seems like it could be long-lasting or 
even permanent. The reliability of the newly 
formulated product will need to be established 
in captive breeding trials with horses before 
one might have the confi dence needed for fi eld 
applications.
Gonacon
At this time, there is only 1 other 
contraceptive product available for use in 
horses. Gonacon™-Equine is a vaccine that 
acts against gonadotropin releasing hormone 
(GnRH), a hormone critical to fertility. The 
vaccine was formulated and registered with the 
Environmental Protection Agency as a 1-shot 
treatment that was thought to provide good 
multiyear effi  cacy. Captive pen trials resulted 
in good effi  cacy (6% foaling) the fi rst year 
(Killian et al. 2008), but again the effi  cacy of a 
single treatment in fi eld trials conducted with 
feral horses at Theodore Roosevelt National 
Park never reached that level of eff ectiveness, 
with about 50% of animals foaling the fi rst and 
second years (Baker et al. 2017). Fortunately, 
with a booster treatment as much as 3 years 
following the initial shot, effi  cacy improved 
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dramatically with 0% of mares foaling a year 
later and around 15% foaling in the following 2 
years. Like PZP vaccines, Gonacon can be hand 
injected or darted. It has 2 advantages in that it 
does not require mixing in the fi eld and is more 
stable when stored. The longer-term effi  cacy of 
Gonacon seems more promising than the PZP 
vaccines at this time; however, optimal booster 
schedules are still being investigated. The BLM 
has used Gonacon in a small pilot project on the 
range, and the early results are encouraging. 
Gonacon treatment that includes a booster may 
be among the best options currently available 
for the contraception of feral horses.
Intrauterine devices
After many years of focusing primarily on PZP 
and GnRH technologies, other contraceptive 
approaches are now being investigated for 
feral horses with support from the BLM (BLM 
2017). In addition to injectable treatments, new 
intrauterine devices (IUDs) are being tested. 
Early studies of IUDs were promising, with 
reports of >80% retention and effi  cacy with 
no negative eff ects on mare health (Daels and 
Hughes 1995). However, once again, when 
additional captive breeding trials were done 
with the same design (as well as other more 
sophisticated designs promoted as eff ective with 
100% retention), the results were disappointing 
with 60–100% of the devices falling out soon 
after stallions were allowed to breed the mares. 
A current BLM-supported study of a new IUD 
has had some success with a redesigned product 
that seems to off er good retention in the presence 
of stallions. Data are still being obtained at this 
time to demonstrate retention, effi  cacy, and 
safety over a period of years. The IUDs have 
the advantage of being almost 100% eff ective as 
long as they are retained. They appear to have 
no long-term negative eff ects on the mare’s 
health or the uterus, and they could be 100% 
reversible if removed. They do have the distinct 
disadvantage that they can only be inserted into 
non-pregnant mares, and most feral horse mares 
of breeding age are pregnant for most of the 
year.
Surgical sterilization
Surgical sterilization, once considered taboo 
for feral horses because it is permanent, is also 
again being considered as a means of reducing 
population growth rates. For stallions, the 
same limitations of polygynandry that became 
apparent back in the 1980s are still present. It 
seems unlikely that castrating or vasectomizing 
only some portion of the more dominant males 
in a herd will signifi cantly slow population 
growth over a period of several years, 
because enough stallions will still be present 
to eventually breed all the mares present. 
However, a saturation approach where some 
high percentage (e.g., 80–95%) of stallions are 
sterilized remains untested. 
In their most recent review of the science 
behind feral horse contraception, the National 
Academy of Sciences recommended chemical 
vasectomy as a promising technique (NRC 
2013). Despite acknowledging that it was not yet 
proven, they felt that it should not be diffi  cult 
to adapt to feral horses. Unfortunately, this 
doesn’t seem to be the case. When chemically 
vasectomized horses were reexamined after 
a recent study performed on the Sheldon 
Wildlife Refuge (Collins and Kasbohm 2016), 
it was revealed that the chemical vasectomies 
failed to block sperm transport in any of the 
dozens of animals treated (Scully et al. 2015). 
While it should be possible to develop and 
use a technique for chemical vasectomy, 
it seems to off er litt le advantage over the 
surgical procedure, which has been done with 
individual horses but remains unproven at the 
population level. The fact that a small number 
of fertile stallions can impregnate many mares 
suggests that any form of vasectomy is unlikely 
to be an eff ective means of long-term population 
growth suppression. 
The consideration of surgical sterilization 
is not limited to stallions but also extends to 
spaying and tubal ligation procedures for 
mares. There is no established procedure for 
tubal ligation in mares. It just is not something 
that is called for among domestic horses and 
has not been developed or tested for feral 
horses. Spaying, while not as common as 
castration, is done in domestic horses and has 
been done with feral horses. The procedure in 
horses is much more diffi  cult than it is in catt le 
and not as routinely practiced as spaying dogs 
and cats, for example. It is almost never done 
to pregnant domestic horses, so the safety and 
practicality of spaying feral horses on a large 
scale, particularly while pregnant, remains 
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mostly untested. 
Feral mares were spayed on the Sheldon 
Wildlife Refuge with a report of fewer foals 
born to harems that included spayed mares and 
vasectomized stallions (Collins and Kasbohm 
2016), but it remains to be seen if similar results 
could be obtained in other places when spaying 
is done on a large scale in the context of typical 
BLM roundups. Yes, individual mares can be 
spayed, but can practitioners do it safely on 
a large scale with pregnant mares, and will it 
help achieve the goal of controlling population 
growth rates? The BLM has att empted to answer 
some of these questions with applied research, 
but these questions remain unanswered largely 
due to litigation that prevented the projects 
from gett ing started.
What is the ideal contraceptive?
We are often asked, why hasn’t anyone 
developed the ideal contraceptive for feral 
horses when the BLM has been supporting this 
research for >40 years? The answer is perhaps 
that an ideal contraceptive is an unreasonable 
expectation for any species. Safety for mares, 
unborn colts, and the environment are 
paramount, but is it really reasonable to expect 
a 1-shot, long-lasting, predictably reversible 
contraceptive that has no behavioral eff ects for 
horses when modern science has never even 
developed such a treatment for dogs, cats, or 
people? The emphasis for reproductive research 
in the domestic horse world has always been 
gett ing mares pregnant, not trying to prevent 
pregnancy. Until the last few years, there has 
been very limited funding for contraceptive 
research for horses with more funding obligated 
by the BLM to research projects in the last few 
years than the previous 40 years combined. From 
where we started in the 1970s, researchers have 
made signifi cant discoveries and improvements 
in contraceptives for feral horses. 
The desperate need for results in the fi eld 
and the limited funding available have meant 
that several treatments were advanced to fi eld 
trials or management use in the fi eld after 
only 1 test under more limited conditions. It 
is not uncommon for treatments that work in 
controlled laboratory or clinical sett ings not to 
work as well when applied on a larger scale in 
the fi eld. Unfortunately, we have seen this with 
feral horse contraception on several occasions. 
Were the early studies fl awed by unblinded, 
biased outcome assessments? What about the 
blinded (Spay Vac) studies that also could not 
be replicated? Was it the biological variation 
in the PZP itself, changes in the adjuvants or 
preparation of the vaccines? All of these factors 
are the reason that research science prefers 
to look for replication of results by diff erent 
investigators under expanded conditions before 
taking treatments to management application 
in the fi eld. However, these are luxuries that 
feral horse contraceptive research didn’t have. 
The pressure and the push have been to 
take treatments to the fi eld as soon as they 
off er some legitimate promise of success. 
The upside would have been faster results 
where they were needed most. The downside 
was several treatments didn’t work as well 
as expected when applied on a large scale. 
These challenges were added to the practical 
limitations and expectations of trying to apply 
darting programs to the typically vast western 
rangelands that span not thousands of acres 
but hundreds of thousands of acres. Darting 
programs can work on a small scale where 
100 or so named animals can be approached to 
within 30 or 40 yards. However, where 10 times 
as many horses might roam on land areas 30 
times larger and the horses can’t be recognized 
as individuals because they mostly look alike, 
this approach is not practicable. Most often 
these animals can’t be approached to less than 
hundreds of yards. Under these more typical 
conditions, darting programs aren’t likely to 
succeed. Despite all this, there have been small-
scale successes on some BLM lands: the Pryor 
Mountains Wild Horse Range and the Litt le 
Book Cliff s, McCullough Peaks, and Spring 
Creek Basin Herd Management Areas come to 
mind.
Conclusion
The history of feral horse contraception 
research is one of desperate need, ambitious 
(perhaps sometimes unreasonable) goals, 
and the passionate pursuit of a solution by a 
handful of investigators challenged by limited 
resources as well as the biology of the endeavor. 
Unfortunately, today, despite the many advances 
that have been made, a contraceptive solution 
that is safe, practical, and eff ective for most 
herds on typical western herds is not in hand. 
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Right now, feral horse contraception research 
has bett er levels of funding than ever before, 
with major universities more engaged than ever 
and new, never previously conceived molecular 
techniques being investigated. Nevertheless, 
progress will likely be slow. For every idea that 
advances to the next level of investigation 2 or 
3 others will fail. Despite the desperate need, if 
we can maintain current research funding levels, 
we are years or likely more than a decade away 
from a contraceptive solution to the challenge 
of signifi cantly reducing feral horse population 
growth rates on western rangelands. The good 
news is that it is still conceivable, and there are 
still some very bright and passionate scientists 
working on solutions that will make a diff erence. 
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